Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Takeda Pharma Plans to Sell Obesity Drug in Japan, Nikkei Says
Bloomberg
Monday, January 25, 2010 - 9:21am
tags:
Japan, obesity, Takeda
Are Forest Labs' Fans Right?
Seeking Alpha
Monday, January 25, 2010 - 9:20am
tags:
Forest Labs
2009's Top Sector for Venture Investment: Biotech
Seeking Alpha
Monday, January 25, 2010 - 9:18am
tags:
venture capital, GlobeImmune, Ironwood, GenVec, AstraZeneca, Novartis, deCODE Genetics
Biotech's Latest Failed Trials, Missed Targets
Seeking Alpha
Monday, January 25, 2010 - 9:16am
tags:
clinical trials, Abbott Laboratories, Pfizer, Merck, Inspire
Genzyme's Outlook Stabilizing
Yahoo/Zacks
Saturday, January 23, 2010 - 12:08pm
tags:
Genzyme
Anadys Pharmaceuticals Provides Progress Update On Phase II Study Of ANA598 In Hepatitis C Patients
Medical News Today
Saturday, January 23, 2010 - 11:29am
tags:
Anadys, hepatitis C
Brazilian president calls for more investment in pharmaceuticals
istockanalyst
Saturday, January 23, 2010 - 11:28am
tags:
Brazil, financial
Pfizer, Auxilium announce start of review of Xiaflex to treat Dupuytren’s contracture
Pharmabiz
Saturday, January 23, 2010 - 11:23am
tags:
Pfizer, Auxilium, Xiaflex, Dupuytren's Contracture
Biovail comments on Teva Pharmaceutical's proposed Budeprion XL trial
The Medical News
Saturday, January 23, 2010 - 11:17am
tags:
Teva Pharmaceuticals, Biovail, Budeprion XL
Dragon Pharmaceutical Gets Acquisition Proposal From CEO Yanlin Han For Price Of $0.80 Per Share
RTT News
Saturday, January 23, 2010 - 11:14am
tags:
Dragon Pharmaceutical
Can Johnson & Johnson Heal Itself?
The Street
Saturday, January 23, 2010 - 11:13am
tags:
JNJ
Big Pharma Eyes Cure For Financing Woes
Yahoo/Investor's Business Daily
Saturday, January 23, 2010 - 11:11am
tags:
Big Pharma
Poniard Pharmaceuticals: A Rebound Is Overdue
Seeking Alpha
Saturday, January 23, 2010 - 11:10am
tags:
Poinard
Pfizer's Great Data Won't Do Much
Motley Fool
Saturday, January 23, 2010 - 11:09am
tags:
Pfizer, Sutent
Forest's Promising COPD Candidate
Yahoo/Zacks
Saturday, January 23, 2010 - 10:53am
tags:
Forrest, aclidinium, COPD
The Take-Away: Statins Are Still in the Cabinet
Forbes
Saturday, January 23, 2010 - 10:53am
tags:
statins
What the New MS Drug (AMPYRA) Does (and What It Doesn’t Do)
Wall Street Journal
Saturday, January 23, 2010 - 10:51am
tags:
Acorda Therapeutics, AMPYRA, multiple sclerosis
Acorda Therapeutics Announces FDA Approval of AMPYRA (dalfampridine) to Improve Walking in People with Multiple Sclerosis - Demonstrated by Increases in Walking Speed
Yahoo/Business Wire
Saturday, January 23, 2010 - 10:48am
tags:
Acorda Therapeutics, AMPYRA, multiple sclerosis
China Cord Blood, GenVec: Biggest Price Gainers (CO, GNVC)
Wall Street Journal
Saturday, January 23, 2010 - 10:47am
tags:
China Cord Blood, GenVec
Aeterna Zentaris Receives NASDAQ Notification Related to Minimum Bid Price
Yahoo/PR NewsWire
Saturday, January 23, 2010 - 10:45am
tags:
Aeterna Zentaris, financial

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.